University of Groningen Brain and retinal macro- and microvasculature Li, Youhai

Brain and retinal macro- and microvasculature Li, Youhai

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Li, Y. (2018). Brain and retinal macro- and microvasculature: Response to ischemic and hyperglycemic stress. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

澳

CHAPTER 6

General discussion

VI

澳

Summary and general discussion

澳

The vasculature of the central nervous system (CNS) is divided into the macrovessels and microvessels, both of which are composed of two principle cell types: the endothelial cells (ECs) lining the inner walls of the vessels, and mural cells (pericytes or smooth muscle cells) enveloping the abluminal surface of the endothelial tube. The macrovessels, most notably the small arteries and arterioles control cerebral blood flow (CBF) and propel the oxygenated blood forward into downstream microvascular networks, whereas the microvessels are responsible for modulating the exchange of gases, nutrients, hormones, ions and metabolites between the circulating blood and parenchyma.

Dysfunction of ipsilateral middle cerebral artery after acute ischemic stroke

Autoregulation of CBF is the ability of the brain vasculature to maintain constant blood flow despite changes in blood pressure (1). The normal vasomotor activity of the middle cerebral artery (MCA) is a critical contributor to the CBF autoregulation. In chapter 2, we designed experiments to investigate the alterations of MCAs after 24 hours of ischemia/reperfusion (I/R) injury. After acute ischemic stroke, the diameter of the ipsilateral middle cerebral artery (MCA) was significantly enlarged compared to that of contralateral MCA (Fig. 1) indicating that the ischemic MCA became dysfunctional including loss of autoregulation and failure to appropriately control blood flow to the ischemic area. This may lead to a worsening of the outcome of ischemic stroke as it can aggravate brain edema or facilitate hemorrhagic transformation (2).

Previous studies reported that in cerebral ischemic stroke the myogenic activity of ischemic MCA was diminished (3, 4). It was suggested that the loss of myogenic tone of ischemic MCA might be associated with dysfunction of smooth muscle cells (SMCs). In chapter 2, we observed that the contractile ability of the SMCs of MCAs upon U46619 (a stable thromboxane A2 (TP) receptor agonist) administration was not affected by I/R injury (Fig. 1; Li Y et al, unpublished data). To uncover the underlying molecular mechanisms of I/R induced MCA dysfunction, we further tested the functions of endothelial cells (ECs) and its signaling interactions with SMCs upon treatment with specific agonists and/or antagonists.

VI

澳

133

澳 澳 Figure 1. Abnormal dilatation of the ipsilateral middle cerebral artery (MCA) following

an acute ischemic stroke in rats. A) Representative images of a rat brain澳following 24 hours

ischemia/reperfusion (I/R) injury. B) The diameter of ipsilateral MCAs is significantly enlarged compared to that of contralateral MCAs (upper panel), whereas the contractile abilities of MCAs from both sides were not different (lower panel). The contractile force of MCAs was calculated after administration of the thromboxane A2 (TP) receptor agonist, U46619 (9,11-Dideoxy-9a,11a-methanoepoxy prostaglandin F2a, 0.3 μM). *Significantly different from

contralateral MCAs.

Upregulation of B2 receptors in the endothelial cells of the ischemic MCAs

In chapter 2, we describe that bradykinin (BK), a potent endothelium-dependent vasodilator, produced a significantly higher relaxation in ipsilateral MCAs compared to either contralateral MCAs or MCAs from healthy rats. Previous studies demonstrated that BK mediates its biological effects via the activation of two receptor subtypes, namely the B1 and B2 receptor, both belonging to the seven-transmembrane G-protein coupled receptor superfamily (5). We found that in the ischemic MCAs preincubation with the B1 receptor antagonist lys-(des-arg΅, leu΄)-BK had no effect on the BK-induced relaxation, whereas the B2 receptor antagonist icatibant completely suppressed the BK-induced relaxation. Furthermore, we showed that B2 mRNA expression was significantly increased in ipsilateral MCAs compared to contralateral MCAs.

BK-induced relaxation was completely澳abolished in endothelium-denuded MCAs. The B2

VI

澳

immunofluorescence staining. These results suggest that activation of B2 receptor

accounts for the BK-induced relaxation, and in the ipsilateral MCAs B2 receptor was

upregulated by the I/R injury.

Signaling pathways of the BK-induced relaxation in the ischemic MCAs

澔

The activation of澳B2 receptors in ECs will increase intracellular calcium [Ca2+]i, which

can trigger downstream pathways (6). Nitric oxide (NO) is a pivotal vasodilator for the endothelium-dependent relaxation by stimulating NO-sensitive guanylyl cyclase in SMCs (7). In mammals, NO can be generated by three different isoforms of the enzyme nitric oxide synthases (NOS): the neuronal isoform (nNOS), the inducible isoform (iNOS) and the endothelial NOS (eNOS) (8). We show in chapter 2, that the NOS inhibitor nitroarginine (L-NNA) or a soluble guanylyl cyclase (sGC) inhibitor ODQ (1H-[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one) almost abolished the sustained relaxant responses to BK while uncovering a transient response in these segments. This observation suggests the involvement of additional signaling pathway, e.g.,

endothelium-dependent hyperpolarization (EDH). Several Ca2+_{-dependent K}+ _channels

(Kca) have been proposed to regulate the EDH process, such as intermediate conductance Kca channel (IKca), small conductance Kca channel (SKca) and big conductance KCa channel (BKca) (9-12). Our results showed that the transient relaxation upon BK occurring in MCAs with the NO-sGC pathway inhibited was completely removed by charybdotoxin (a blocker of BKca and IKca), but not apamin (a selective blocker of SKca) or iberiotoxin (a selective blocker of BKca), suggesting that IKca channel activation accounts for the BK-induced EDH. Taken together, in

chapter 2 we demonstrate that upregulation of B2 receptor expression within

endothelium of ipsilateral MCAs is responsible for the BK-induced significant vasodilatation, which is mediated via two signaling pathways between ECs and SMCs

(Fig. 2). Our findings demonstrate for the first time that澳the function of endothelial cells

in ischemic MCAs is altered by I/R injury. The main effector appears to be a significant upregulation of the underlying B2 receptor expression.

VI

澳

135

澳 澳 Figure 2. Schematic paragraph showing the signaling pathways of the BK-induced relaxation in the middle cerebral artery (MCA) after acute ischemic stroke. BK,

bradykinin; eNOS, endothelial nitric oxide synthase; IKca, intermediate conductance Kca

channel; EC, endothelial cell of the ischemic MCA; SMC, smooth muscle cell of the ischemic MCA.

Newly established protocol for isolating brain and retinal microvessels from healthy and diabetic rats

The molecular exchange between circulating blood and CNS parenchyma takes place in the microvascular networks, which mainly consist of two interacting cell types: endothelial cells (ECs) and pericytes (PCs). In order to explore the cellular and molecular properties of retinal and brain microvasculature, in chapter 3, we first developed a new mechanical method for isolation of retinal microvessels (RMVs) and brain microvessels (BMVs) from the same rats. Morphometric analysis showed that the density of PCs in RMVs was significantly higher than in BMVs, in terms of the mean distance of neighboring PCs (45 μm in RMVs versus 61 μm in BMVs) and the endothelial cell/pericyte ratio (1.8 in RMVs versus 2.7 in BMVs). This is consistent with previous reports, in which the pericyte coverage in BMVs (either rat or monkey) was significant less as compared to RMVs (13, 14). In addition, our gene expression data show significant accumulation of endothelial cell- and pericyte-specific markers in the RMVs and BMVs isolated from both healthy and diabetic rats. These results demonstrate that our new established protocol can yield high amounts and highly

VI

澳

integrity of these isolated microvessels is well preserved

Different susceptibility to diabetes

In mammals, brain and retinal microvasculature form two comparable blood-neuronal barriers, namely blood-brain barrier (BBB) and inner blood-retinal barrier (iBRB) (15, 16) for maintaining a microenvironment that allows neurons to function properly. The

molecular movements in CNS between blood and澳parenchyma are tightly regulated by

the ECs barriers that are characterized by the presence of extensive intercellular junctions, absence of fenestrations and an extremely low rate of transcytosis (17). Pericytes partially embrace the abluminal side of ECs (range from 10% to 50% depending on the supplied tissue) and send finger-like projections inserted into endothelial invaginations with N-cadherin–mediated peg-and-socket junctions (18). Many studies have demonstrated that pericyte plays a crucial role in the development and maintenance of BBB and iBRB (19, 20). In diabetes, reduction of pericyte coverage on the retinal microvasculature has been proposed as a key event that contributes to microvascular dysfunction including the breakdown of iBRB and the formation of acellular capillaries in diabetic retinopathy (21-23). However, in the brain microvasculature, the pericyte coverage is not changed by diabetes (24). This interesting phenomenon produced two questions: why BMVs that have less pericyte coverage do not show microvessel leakage, in other words, how BMVs are able to keep PCs and ECs stabilization in chronic hyperglycemia of diabetes.

Molecular interactions between endothelial cells and pericytes of microvessels

During the development of the microvessels, sprouting ECs synthesize and secrete platelet derived growth factor beta (PDGFb), which binds with high affinity to the pericyte-specific receptor PDGFRb, resulting in the proliferation and recruitment of PCs (25). There are two basic purposes/functions for PCs embracing on the abluminal side of ECs: (i) stabilizing newly formed endothelial tubules (26) and (ii) contributing to the formation/maintenance of endothelial barriers (e.g., BBB and iBRB) (19). Tight regulation and close coordination between ECs and PCs are necessary to form a

VI

澳

137

澳 澳 network of mature microvessels. At a molecular level, the pericyte coverage on microvessels is regulated by the crosstalk between ECs and PCs. Several signaling pathways have been demonstrated to be pivotal in the ECs/PCs interactions, such as the PDGFb/PDGFRb signaling pathway (as mentioned above), the angiopoietin/Tie2 signaling pathway and the TGFβ signaling pathway (27). Activation of Tie2 receptors (in ECs) by angiopoietin 1 (Ang1, from PCs) promotes vessel stabilization and maturation (28), whereas angiopoietin 2 (Ang2, in ECs) binding to Tie2 triggers cell migration, proliferation and vessel leakage (29, 30). Similarly, the biological effects of TGFβ also depend on its receptors: activation of activin receptor-like kinase 5 (Alk5, also known as TGFβ receptor-1) will promote vessel stabilization while Alk1 activation triggers cell migration, proliferation and vessel destabilization (28). In chapter 4, using transcriptome analysis, we found that expression of Ang1 in BMVs was significantly higher than in RMVs, while Tie2 and Ang2 expression were comprable between BMVs and RMVs. These results indicate that the microvessel stablity and maturation remains more secure in BMVs than in RMVs.

In addition to the signaling crosstalk, ECs also directly contact with PCs in areas lacking the basement membrane, through abundant ECs-PCs gap junctions (GJs) made up by different connexins (e.g., Cx37 and Cx43) (31). Previous studies demonstrated that reduction of GJs expression contributed to compromised vascular homeostasis (32), impaired mural cell differentiation (33) and endothelial barrier damage (34, 35). In

chapter 4, we observed that the expression levels of Cx37, Cx40 and Cx43 were

significantly higher in BMVs than in RMVs. Therefore, one may conclude that higher expression of Ang1 and connexins genes in BMVs in turn enable BMVs to have more intravascular stabilization than in RMVs.

Effects of chronic hyperglycemia on retinal and brain microvasculature

澔

In brain and retina, blood glucose is transported rapidly through the ECs by the glucose transporter 1 (Glut-1) (36). After cellular uptake, glucose in ECs is mainly split

into pyruvate澳for adenosine triphosphate (ATP) production via the aerobic glycolysis

pathway (Fig. 3, 4) (37). In the past decades, multiple molecular mechanisms have been proposed to explain the pathogenesis of diabetic microvascular complications, including hyperglycemia-induced reactive oxidative species (ROS) overproduction,

VI

澳

C (PKC) and NF-κB pathway activation (Fig.3) (38-41). Most of these theories are based on studies using hyperglycemia-susceptible organs (e.g., retina), but they never elucidate why the closely related brain microvasculature is not or less susceptible to diabetes.

In chapter 5 we found in diabetes, that gene expression patterns of BMVs and RMVs were distinct. Depending on the functional properties, these altered genes are divided into four major categories as described below.

i) Genes related to ROS production. Stanniocalcin-1 (Stc-1) and Bhlhe40 are two enzymes that can suppress the ROS generation (42-46). NAD(P)H dehydrogenase 1

(Nqo1) and Glutathione S-transferase P (Gstp1) are pivotal antioxidant澳enzymes in

response to DNA damage by ROS injury (47-49). Under diabetic conditions, Stc-1 and Bhlhe40 genes were significantly upregulated in BMVs, while Nqo1 and Gstp1 genes were significantly downregulated in RMVs, suggesting that in BMVs the oxidative stress induced by diabetes might be counterbalanced by antioxidants although more studies are required to elucidate this relation.

ii) Genes related to methylglyoxal production. Methylglyoxal (MG), a major precursor of advanced glycation end products (AGEs), is derived primarily from dihydroxyacetone phosphate (DHAP) (50, 51). Under diabetic conditions, expression of glycerol-3-phosphate dehydrogenase 1 (Gpd1) was significantly upregulated in BMVs whereas it was not changed in RMVs. Previous studies showed that Gpd1 is an enzyme that converts DHAP into glycerol-3-phosphate (G3P) with a decrease in the

NADH/NAD+ _{ratio (52). This process can reduce cellular concentration of DHAP and}

prevent the spontaneous conversion of DHAP into MG (53). The overexpression of Gpd1 in BMVs might reduce MG formation in the brain microvasculature, thereby diminishes the diabetic insults.

iii) Genes related to inflammation. Neuron-derived orphan receptor 1 (Nr4a3) and TSC22 domain family protein 3 (Tsc22d3) have anti-apoptotic effects through prevention of NF-κB activation (54-56), while TNF receptor superfamily member 21 (Tnfrsf21, so-called DR6) can activate the NF-κB pathway and trigger cell apoptosis (57). Under diabetic conditions, we observed that in BMVs, Nr4a3 and TSC22 genes

VI

澳

139

澳 澳 were significantly upregulated, meanwhile Tnfrsf21gene was significantly downregulated. All these genes were not changed in RMVs, suggesting that in diabetes, the anti-inflammatory capacity of BMVs seems to be enhanced by inhibition of the NF-κB pathway.

iv) Genes related to protein translation. Aminoacyl-tRNA synthetases (aaRSs) catalyze the ligation of amino acids to their cognate tRNAs, thereby playing a key role in protein synthesis (58). In addition to the aminoacylation function, many studies have shown that aaRSs have multiple non-canonical functions, e.g., regulation of glucose metabolism and inflammation (59, 60). Under diabetic conditions, we observed that expression of Nars, Gars, Mars, Iars and Yars (5 components of aaRSs) in RMVs were significantly upregulated. Previous studies have shown that oxidative stress can cause damage to aaRSs functions, followed by amino acid mistranslation and protein misfolding (61, 62). We thus speculate that in RMVs, hyperglycemia-induced

superoxide causes upregulation of aaRSs genes, which in turn affects澳the glucose

metabolism, inflammation and reliability of protein translation in RMVs (Fig. 3). Taken together, we demonstrated that in diabetes, BMVs have multiple defense mechanisms including reduction of ROS production, reduction of glycolytic intermediates and enlarged anti-inflammatory capacity, against the detrimental effects of diabetes (Fig. 4). In contrast, these protective systems were not activated or even suppressed in RMVs (Fig. 3). Based on these findings, it is not surprising to observe that the brain microvasculature is less susceptible to diabetes as compared to the retinal microvasculature.

VI

澳

VI

澳

141

澳 澳 Figure 4. Schematic representation of the defense mechanisms of brain microvessels in the hyperglycemia of diabetes. Blood glucose is transported to the brain microvascular

endothelial cells by the glucose transporter 1

澳 澳 澳

VI

澳

Conclusions

With regard to macrovesssels, our studies demonstrate that after the acute ischemic stroke, the B2 receptor in the ECs of ischemic MCA was overexpressed, and activation of B2 receptor lead to MCA dilatation via two signaling pathways between ECs and

underling SMCs: 1) the B2-eNOS-sGC signaling pathway, and 2) B2-IKca-EDH

signaling pathway. Upregulation of B2 receptor likely contributes to the abnormal enlargement of ischemic MCA. With regard to microvessels, we developed a new method for both RMVs and BMVs isolation from individual rats. The morphological analysis demonstrated that in rat, the pericyte density in RMVs was higher as compared to BMVs, in term of EC/PC ratio and PC-PC distance. In physiological conditions, we have shown that the expression levels of Cx37, Cx40, Cx43 and Ang1 were significantly higher in BMVs as compared to RMVs. Under diabetic conditions, we have shown that several compensatory mechanisms appeared in BMVs, including reduction of glycolytic intermediates, reduction of ROS production and enlarged anti-inflammatory capacity, whereas these defense systems were not activated or even suppressed in RMVs. These findings help to understand why retinal and brain

microvasculature show different susceptibilities to diabetes, which may contribute to澳

new approaches in drug development for the treatment of vascular complications in diabetes.

VI

澳

143

澳 澳

Future perspectives

Part I: Utilization of the new protocol for microvessel isolation

In this thesis, we have described a new protocol for isolating rat RMVs and BMVs, which were used to identify the diabetes changed genes. In the next step we will use our protocol to isolate the RMVs and BMVs from acute brain ischemic rats and to assess the gene expression alterations of those microvascular beds in the early stage of ischemic stroke. Our preliminary studies showed that this protocol can be used with a little modification for isolating the BMVs from ob/ob mice (Li Y et al, unpublished data). With the help of this modified protocol, we will be able to explore the molecular profiles of mice brain microvascular beds in front of diabetic or ischemic stroke insult. In the future we also can modified our protocol to isolate human RMVs and BMVs in both healthy and pathological conditions (e.g. diabetes and ischemic stroke), which might help to uncover the molecular mechanisms of these diseases.

Figure 5. The microscopic images showing the high amount and high purity of brain

microvessels isolated from one ob/ob mice. Images are stained with haemotoxylin and eosin

VI

澳

Part II: Molecular functions of the diabetic changed genes in RMVs and BMVs

Our animal studies demonstrated that in diabetes the gene expression patterns of retinal and brain microvasculature were distinct. The functional properties of these identified genes were descripted according to the previous observations, such as Nr4a3 preventing the activation of NF-κB pathway (55), Gpd-1 preventing the formation of MG (53). Based on the previous literature, we speculated that in diabetes, the BMVs expressed

multiple澳complementary mechanisms to diminish the toxic effects of diabetes, whereas

these processes are not activated or suppressed in the RMVs. However, because most of those reports were performed on non-vascular cells, the functional role of those genes in vascular endothelial cells is at present unknown. Besides, the molecular mechanisms of how these genes were transcriptionally changed are not clear. Therefore, to gain more insight in the understanding of the transcriptional alterations of retinal and brain microvessels in diabetes, more studies are required. Below I give an example for uncover the functional role of diabetic changed gene.

澳

Nr4a3, also known as NOR-1, is a ligand-independent transcription factor. Our animal studies showed that the expression level of Nr4a3 mRNA in BMVs was significantly increased by diabetes. Human umbilical vein endothelial cells (HUVEC) are widely used to study the molecular processes of vasculature under high glucose conditions. In

chapter 5 of this thesis, in vitro studies on HUVECs showed that Nr4a3 mRNA

expression was significantly upregulated by high glucose treatment. To further study the role of Nr4a3 upregulation, gene silencing to knock down Nr4a3 in HUVECs can be used. Short interfering RNA (siRNA), a tool for inducing short-term silencing of genes, can assist in elucidating the response of endothelial cells to high glucose in the low expression of Nr4a3. Preliminary studies showed that Nr4a3 gene silencing using siRNA can be accomplished with more than 70% reduction in HUVECs (Y Li et al, unpublished data). It has been reported that Nr4a3 upregulation in vascular smooth muscle cells can inhibit the activation of NF-κB pathway (55). The potential anti-inflammatory function of Nr4a3 can be studied, for example, by determining the

expression of adhesion molecules (e.g. E-selectin), chemokines (e.g.澳interleukin-8) in

VI

澳

145

澳 澳

References

1. van Beek AH, Claassen JA, Rikkert MG, & Jansen RW (2008) Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. Journal of cerebral blood flow and metabolism 28(6):1071-1085.

2. Nour M, Scalzo F, & Liebeskind DS (2013) Ischemia-reperfusion injury in stroke.

Interventional neurology 1(3-4):185-199.

3. Cipolla MJ, Lessov N, Hammer ES, & Curry AB (2001) Threshold duration of ischemia for myogenic tone in middle cerebral arteries: effect on vascular smooth muscle actin. Stroke 32(7):1658-1664.

4. Cipolla MJ & Curry AB (2002) Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity. Stroke 33(8):2094-2099. 5. Hall JM (1992) Bradykinin receptors: pharmacological properties and biological roles.

Pharmacology & therapeutics 56(2):131-190.

6. Kuhr F, Lowry J, Zhang Y, Brovkovych V, & Skidgel RA (2010) Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors.

Neuropeptides 44(2):145-154.

7. Forstermann U & Sessa WC (2012) Nitric oxide synthases: regulation and function.

European heart journal 33(7):829-837, 837a-837d.

8. Sandoo A, van Zanten JJ, Metsios GS, Carroll D, & Kitas GD (2010) The endothelium and its role in regulating vascular tone. The open cardiovascular medicine journal 4:302-312.

9. Crane GJ, Gallagher N, Dora KA, & Garland CJ (2003) Small- and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. The Journal of physiology 553(Pt 1):183-189.

10. Hannah RM, Dunn KM, Bonev AD, & Nelson MT (2011) Endothelial SK(Ca) and IK(Ca) channels regulate brain parenchymal arteriolar diameter and cortical cerebral blood flow. Journal of cerebral blood flow and metabolism : official journal of the

International Society of Cerebral Blood Flow and Metabolism 31(5):1175-1186.

11. Bychkov R, et al. (2002) Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF. British journal of pharmacology 137(8):1346-1354.

12. Marrelli SP, Eckmann MS, & Hunte MS (2003) Role of endothelial intermediate conductance KCa channels in cerebral EDHF-mediated dilations. American journal of

VI

澳

capillaries. Investigative ophthalmology & visual science 31(6):999-1007.

14. Frank RN, Dutta S, & Mancini MA (1987) Pericyte coverage is greater in the retinal than in the cerebral capillaries of the rat. Investigative ophthalmology & visual science 28(7):1086-1091.

15. Huber JD, Egleton RD, & Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends in neurosciences 24(12):719-725. 16. Diaz-Coranguez M, Ramos C, & Antonetti DA (2017) The inner blood-retinal barrier:

Cellular basis and development. Vision research 139:123-137.

17. Zhao Z, Nelson AR, Betsholtz C, & Zlokovic BV (2015) Establishment and Dysfunction of the Blood-Brain Barrier. Cell 163(5):1064-1078.

18. Daneman R (2012) The blood-brain barrier in health and disease. Annals of neurology 72(5):648-672.

19. Trost A, et al. (2016) Brain and Retinal Pericytes: Origin, Function and Role. Frontiers

in cellular neuroscience 10:20.

20. Daneman R, Zhou L, Kebede AA, & Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468(7323):562-566.

21. Hammes HP, et al. (2002) Pericytes and the pathogenesis of diabetic retinopathy.

Diabetes 51(10):3107-3112.

22. Rask-Madsen C & King GL (2013) Vascular complications of diabetes: mechanisms of injury and protective factors. Cell metabolism 17(1):20-33.

23. Durham JT, Dulmovits BM, Cronk SM, Sheets AR, & Herman IM (2015) Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy? Investigative ophthalmology & visual science 56(6):3441-3459.

24. Armulik A, Abramsson A, & Betsholtz C (2005) Endothelial/pericyte interactions.

Circulation research 97(6):512-523.

25. Jain RK (2003) Molecular regulation of vessel maturation. Nature medicine 9(6):685-693.

26. Warmke N, Griffin KJ, & Cubbon RM (2016) Pericytes in diabetes-associated vascular disease. Journal of diabetes and its complications 30(8):1643-1650.

27. Gaengel K, Genove G, Armulik A, & Betsholtz C (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arteriosclerosis, thrombosis, and

vascular biology 29(5):630-638.

28. Hammes HP, Feng Y, Pfister F, & Brownlee M (2011) Diabetic retinopathy: targeting vasoregression. Diabetes 60(1):9-16.

VI

澳

147

澳 澳

and High Ang-2/Ang-1 Protein Ratio are Associated with Early Onset Sepsis in Surinamese Newborns. Shock 48(6):638-643.

30. Winkler EA, Bell RD, & Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nature neuroscience 14(11):1398-1405.

31. Tien T, Muto T, Barrette K, Challyandra L, & Roy S (2014) Downregulation of Connexin 43 promotes vascular cell loss and excess permeability associated with the development of vascular lesions in the diabetic retina. Molecular vision 20:732-741. 32. Hirschi KK, Burt JM, Hirschi KD, & Dai C (2003) Gap junction communication

mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circulation research 93(5):429-437.

33. Chen CH, et al. (2015) The connexin 43/ZO-1 complex regulates cerebral endothelial F-actin architecture and migration. American journal of physiology. Cell physiology 309(9):C600-607.

34. Rhett JM, Jourdan J, & Gourdie RG (2011) Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Molecular biology of the cell 22(9):1516-1528.

35. Kumagai AK (1999) Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes/metabolism research and reviews 15(4):261-273.

36. Goveia J, Stapor P, & Carmeliet P (2014) Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO

molecular medicine 6(9):1105-1120.

37. Giacco F & Brownlee M (2010) Oxidative stress and diabetic complications.

Circulation research 107(9):1058-1070.

38. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications.

Nature 414(6865):813-820.

39. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism.

Diabetes 54(6):1615-1625.

40. Busik JV, Mohr S, & Grant MB (2008) Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 57(7):1952-1965.

41. Takeshita S, et al. (2012) Bhlhe40, a potential diabetic modifier gene on Dbm1 locus, negatively controls myocyte fatty acid oxidation. Genes & genetic systems 87(4):253-264.

42. Chung SY, et al. (2015) Bhlhe40 Represses PGC-1alpha Activity on Metabolic Gene Promoters in Myogenic Cells. Molecular and cellular biology 35(14):2518-2529. 43. Liu D, Shang H, & Liu Y (2016) Stanniocalcin-1 Protects a Mouse Model from Renal

VI

澳

Pathways. International journal of molecular sciences 17(7).

44. Pan JS, et al. (2015) Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. Journal of the American Society of

Nephrology : JASN 26(2):364-378.

45. Liu D, et al. (2012) Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway. PloS one 7(5):e36994.

46. Jiang T, et al. (2010) The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 59(4):850-860.

47. Xu Z, et al. (2014) NRF2 plays a protective role in diabetic retinopathy in mice.

Diabetologia 57(1):204-213.

48. Gorrini C, Harris IS, & Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nature reviews. Drug discovery 12(12):931-947.

49. Wang J, et al. (2014) CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina. Acta diabetologica 51(5):813-821.

50. Rabbani N & Thornalley PJ (2014) The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy. Diabetes 63(1):50-52.

51. Shen W, et al. (2006) Involvement of a glycerol-3-phosphate dehydrogenase in modulating the NADH/NAD+ ratio provides evidence of a mitochondrial glycerol-3-phosphate shuttle in Arabidopsis. The Plant cell 18(2):422-441.

52. Kumar S, Singh R, Williams CP, & van der Klei IJ (2016) Stress exposure results in increased peroxisomal levels of yeast Pnc1 and Gpd1, which are imported via a piggy-backing mechanism. Biochimica et biophysica acta 1863(1):148-156.

53. Cheng Q, et al. (2013) GILZ overexpression inhibits endothelial cell adhesive function through regulation of NF-kappaB and MAPK activity. Journal of immunology 191(1):424-433.

54. Calvayrac O, et al. (2015) NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFkappaB activation. Journal of molecular and

cellular cardiology 80:34-44.

55. Lee MJ, et al. (2016) Low expression of the GILZ may contribute to adipose inflammation and altered adipokine production in human obesity. Journal of lipid

research 57(7):1256-1263.

56. Pan G, et al. (1998) Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS letters 431(3):351-356.

VI

澳

149

澳 澳

cell signaling functions of the protein translation machinery. Vascular pharmacology 52(1-2):21-26.

58. Yao P & Fox PL (2013) Aminoacyl-tRNA synthetases in medicine and disease. EMBO

molecular medicine 5(3):332-343.

59. Park SG, Schimmel P, & Kim S (2008) Aminoacyl tRNA synthetases and their connections to disease. Proceedings of the National Academy of Sciences of the United

States of America 105(32):11043-11049.

60. Netzer N, et al. (2009) Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature 462(7272):522-526.

61. Ling J & Soll D (2010) Severe oxidative stress induces protein mistranslation through impairment of an aminoacyl-tRNA synthetase editing site. Proceedings of the National